For research use only. Not for therapeutic Use.
SAMT-247(Cat No.:I012244)is a small molecule inhibitor that targets specific signaling pathways involved in the growth and survival of cancer cells. It has been primarily studied for its potential application in treating hematologic malignancies, including leukemia and lymphoma. SAMT-247 works by inhibiting key proteins that regulate cell proliferation and survival, leading to cancer cell apoptosis. Additionally, it has been shown to modulate the tumor microenvironment and enhance immune responses. Though promising in preclinical models, further clinical trials are needed to assess its safety, efficacy, and potential as a treatment for various cancers.
Catalog Number | I012244 |
CAS Number | 850715-59-2 |
Synonyms | N-[2-Acetylthiobenzoyl]-beta-alaninamide |
Molecular Formula | C12H14N2O3S |
Purity | ≥95% |
Target | HIV |
IUPAC Name | S-[2-[(3-amino-3-oxopropyl)carbamoyl]phenyl] ethanethioate |
InChI | InChI=1S/C12H14N2O3S/c1-8(15)18-10-5-3-2-4-9(10)12(17)14-7-6-11(13)16/h2-5H,6-7H2,1H3,(H2,13,16)(H,14,17) |
InChIKey | UNACIIIRYSLSOD-UHFFFAOYSA-N |
SMILES | CC(=O)SC1=CC=CC=C1C(=O)NCCC(=O)N |